Kazia Therapeutics Appoints James Levine as Chief Financial Officer
Go back to Kazia Therapeutics Appoints James Levine as Chief Financial Officer| (NASDAQ: KZIA) | Delayed: 12.81 -0.01 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.82 | 52 Week High | $ | |||
| Open | $13.13 | 52 Week Low | $ | |||
| Day High | $13.55 | P/E | N/A | |||
| Day Low | $12.52 | EPS | $ | |||
| Volume | 96,548 | |||||

